PEN-221 is discontinued for commercial reason. References: White BH, Whalen K, Kriksciukaite K, Alargova RG, Au Yeung T, Bazinet P, Brockman AH, Dupont M, Oller H, Lemelin CA, Lim Soo P, Moreau B, Perino S, Quinn JM, Sharma G, Shinde R, Sweryda-Krawiec B, Wooster R, Bilodeau MT. Discovery of an SSTR2-targeting maytansinoid conjugate (PEN-221) with potent activity in vitro and in vivo. J Med Chem. 2019 Feb 8. doi: 10.1021/acs.jmedchem.8b02036. [Epub ahead of print] PubMed PMID: 30735385.

纯度：≥98%

CAS：1853254-97-3